Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 19Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Neoplasm, Residual 2Neoplasm Metastasis 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Waldenstrom Macroglobulinemia 1Turcot syndrome 1Testicular Neoplasms 1Surgery 1Stress, Psychological 1Squamous Cell Carcinoma of External Auditory Canal 1Solitary Fibrous Tumor, Pleural 1Seminoma 1Sarcoma 1Recurrence 1Postoperative Complications 1

Interventions

Cyclophosphamide 13Specimen Handling 9cabozantinib 8X-Rays 8Magnetic Resonance Spectroscopy 8fludarabine 7Phantoms, Imaging 7Biopsy 7Temozolomide 6Methotrexate 6Zoledronic Acid 5Gemcitabine 5Doxorubicin 5regorafenib 4pembrolizumab 4Vincristine 4Nuclear Medicine Department, Hospital 4Nivolumab 4Ifosfamide 4Cisplatin 4olaparib 3irinotecan sucrosofate 3fludarabine phosphate 3dinutuximab 3Surveys and Questionnaires 3Irinotecan 3Etoposide 3ulixertinib 2tipifarnib 2tazemetostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Neoadjuvant Therapy × 1 year × Clear all
NCT07142863 2025-08-27

Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Not yet recruiting
23 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡